CClinicalTrials.gg
Status unknownNCT05075018Updated Apr 6, 2022

Musculoskeletal Problems and Endurance in Healthcare Professionals With and Without COVID-19

An observational study in COVID-19 Respiratory Infection, sponsored by Abant Izzet Baysal University. Status unknown at 1 site in Turkey. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-04-06.

Sponsored by Abant Izzet Baysal University · Observational

The sponsor has not verified this record recently (last verified Apr 2022), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
36
Ages
18 Years to 65 Years
Sex
All
01

Study summary

The effects of frequency and severity of physical complaints and symptoms on general well-being, sleep and quality of life are known. However, in the COVID-19 process, the disease has very different effects, both physical and psychological, and some symptoms persist even if the disease is overcome; In addition to these, the fact that the measures taken throughout the country prompt individuals to take measures to protect themselves from the disease and make it compulsory under some conditions intertwine many different dimensions of the disease on human health and significantly affect daily life. In this context, our first aim in this study is to compare factors such as musculoskeletal problems, physical activity level, endurance and quality of life in healthcare workers with and without COVID-19. Seconder aim is to examine the relationships between factors such as musculoskeletal problems, physical activity level, endurance and quality of life, and to examine the effect levels of the parameters by performing regression analyzes depending on the result.

Read the detailed description

COVID-19 (The coronavirus disease 2019), COVID-19 infection with a wide variety of symptoms such as pain, shortness of breath, high fever, loss of taste and smell, diarrhea and can even progress to a very serious condition such as acute respiratory distress syndrome. It is a common disease that has manifested itself worldwide in the last 1 year as a disease and was declared a pandemic by the World Health Organization on March 11, 2020.

80% of the cases have mild or asymptomatic disease, and 20% need treatment in hospital conditions. Although the disease affects different age groups, it generally affects people aged 60 and over more. It can take weeks to get over the disease; however, some symptoms persist even after the infection has cleared. The continuation of physical, cognitive and psychological problems in COVID-19 patients recovering from the acute phase of the disease is called 'Post-COVID-19 Syndrome'. Symptoms of the disease include fever, dry cough and shortness of breath, as well as common musculoskeletal problems such as muscle pain, joint pain and fatigue, anxiety, depression, poor sleep quality and decreased quality of life, and difficulties in daily living activities. Moreover, the course and prevalence of the disease and its severity in our country as well as in the world have developed a new psychological pressure about the disease and revealed the situation of coronavirus phobia, and even this affects the mood and sleep quality of individuals. It has been shown that depression and anxiety are observed, especially in patients with severe respiratory-related symptoms, both during the active period of the disease and during the period when the symptoms continue despite the recovery of the disease, and the quality of life is adversely affected.

The effects of frequency and severity of physical complaints and symptoms on general well-being, sleep and quality of life are known. However, in the COVID-19 process, the disease has very different effects, both physical and psychological, and some symptoms persist even if the disease is overcome; In addition to these, the fact that the measures taken throughout the country prompt individuals to take measures to protect themselves from the disease and make it compulsory under some conditions intertwine many different dimensions of the disease on human health and significantly affect daily life. In this context, our first aim in this study is to compare factors such as musculoskeletal problems, physical activity level, endurance and quality of life in healthcare workers with and without COVID-19. Seconder aim is to examine the relationships between factors such as musculoskeletal problems, physical activity level, endurance and quality of life, and to examine the effect levels of the parameters by performing regression analyzes depending on the result.

02

Conditions studied

  • COVID-19 Respiratory Infection

Keywords

  • COVID-19
  • Muscle Endurance
  • Musculoskeletal Problems
  • Healthcare Workers
03

In context

Infections

6,688 studies on the registry are indexed under Infections; 807 are open to participants now.

This study's planned enrollment of 36 is below the median of 240 across 2,136 observational studies indexed under Infections.

Browse Infections studies →

Lead sponsor

Abant Izzet Baysal University is the lead sponsor of 242 studies on the registry; 64 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Participants are health workers working in a health institution; It will consist of two groups, those who have been diagnosed with COVID-19 in the past and those who have not been diagnosed with COVID-19 in the past.

Inclusion criteria

  • Volunteering,
  • Being a healthcare worker

Exclusion criteria

Exclusion Criteria:

  • Using psychiatric medication
  • No surgery in the last 6 months
05

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
36 participants (estimated)
Patient registry
No

Groups and cohorts

  • Healthcare Workers with COVID-19 Infection

    Healthcare workers who have been diagnosed with COVID-19 in the past and currently do not have COVID-19 disease constitute this group

    Other: Observational

  • Healthcare Workers without COVID-19 Infection

    Healthcare workers who have not been diagnosed with COVID-19 in the past and currently do not have COVID-19 disease constitute this group

    Other: Observational

Interventions

  • OtherObservational

    Individuals' musculoskeletal problems will be evaluated with the Cornell Musculoskeletal Disorder Questionnaire, quality of life, physical activity, Nottingham Health Profile physical activity International Physical Activity Questionnaire, endurance stabilizer device, functional exercise capacity 1 minute sit and stand test, shortness of breath using the Modified Borg Scale. Measurements will be made only once.

06

What researchers measure

Primary outcomes

  1. Measurement of the Endurance

    Endurance of deep cervical flexor muscles and core muscles (Transversus abdominous muscle and lumbar multifidus muscle) will be evaluated with The Stabilizer Pressure Biofeedback Unit. The device will be placed on the measured muscles; Individuals will be asked to maintain their position at the desired pressures. It will give the individual the time to maintain the desired value and the pressure score. High scores indicate that endurance is preserved; low scores reflect loss of endurance.

    Time frame: 15 minutes

Secondary outcomes

  1. Cornell Musculoskeletal Discomfort Questionnaire

    The scale divides the body into 20 distinct regions. Each region's score ranges from 0 to 90. It is understood that the higher the score, the greater the pain, the severity of the pain and the limitation of the pain.

    Time frame: 5 minutes

  2. Nottingham Health Profile

    The Nottingham Health Profile will be used to assess health-related quality of life. The questionnaire consists of 38 items and consists of six subsections related to health status: Energy, pain, emotional reactions, sleep, social isolation and physical activity. Each section is scored between 0-100. 0 indicates best health, 100 indicates worst health.

    Time frame: 10 minutes

  3. International Physical Activity Questionnaire

    Physical activity level will be measured with the International Physical Activity Questionnaire. The questionnaire evaluates parameters such as vigorous activities, moderate activities, walking and sitting activities. The higher the score, the higher the physical activity; A low score indicates physical inactivity.

    Time frame: 5 minutes

  4. 1 minute sit to stand test

    Sit and stand test can be performed to evaluate functional exercise capacity, lower extremity muscle strength and endurance. Individuals are asked to cross their arms over their shoulders and sit and stand up for 30 seconds as fast and as long as they can, and the number of sit-ups is recorded. High scores indicate good functional capacity, strength and endurance; low scores indicate functional impairment.

    Time frame: 2 minutes

  5. Modified Borg Scale

    Dyspnea assessment will be made with the Modified Borg Scale. Scoring ranges from 0 to 10 points. High scores indicate high dyspnea; low scores indicate low breathlessness.

    Time frame: 2 minutes

07

Study locations

1 of 1 sites recruiting
  • Düzce Atatürk Devlet Hastanesi
    Düzce, 81060, Turkey
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 6, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05075018
Lead sponsor
Abant Izzet Baysal University
Responsible party
Sponsor
First posted
Oct 12, 2021
Start date
Sep 30, 2021
Primary completion
Jun 20, 2022 (estimated)
Completion
Jul 20, 2022 (estimated)
Last update
Apr 6, 2022

Study contacts

Eylem TÜTÜN YÜMİN, Assoc. Prof.
Contact
eylemtutun78@hotmail.com
+90 505 676 31 91
Reşat HAMURCU
Contact
fztresathmrc@gmail.com
+90 552 664 46 68
Eylem TÜTÜN YÜMİN, Assoc. Prof.
study director · Bolu Abant İzzet Baysal University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Apr 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion